Clinical Trial Update: Isoniazid Prophylaxis Based on Risk Factors of Tuberculosis in Living Kidney Transplantation Recipients [NA]

View source ↗

Summary

A completed clinical trial evaluated isoniazid prophylaxis for TB prevention in living kidney transplant recipients based on TB risk factors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• ISONIAZID (ISONIAZID)

Snippet

Sponsor: West China Hospital | Conditions: Kidney Transplantation, Tuberculosis | NA | Status: COMPLETED